Get the Stockscreener App
0.78
3.59%
-0.0301
Clearmind Medicine Inc stock is traded at $0.78, with a volume of 133.53K.
It is down -3.59% in the last 24 hours and down -21.90% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$0.8101
Open:
$0.79
24h Volume:
133.53K
Relative Volume:
0.15
Market Cap:
$4.26M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0183
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
-21.11%
1M Performance:
-21.90%
6M Performance:
-22.61%
1Y Performance:
-44.21%
1-Day Range:
$0.773
$0.80
1-Week Range:
$0.75
$1.20
52-Week Range:
$0.75
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.78 | 4.43M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.42 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.32 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.61 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.02 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.88 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Clearmind Medicine Inc Stock (CMND) Latest News
Intraday pattern recognizer results for Clearmind Medicine Inc.2025 Trading Recap & AI Driven Price Predictions - newser.com
How sentiment analysis helps forecast Clearmind Medicine Inc.Quarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - newser.com
Price momentum metrics for Clearmind Medicine Inc. explainedProduct Launch & Fast Entry Momentum Alerts - newser.com
Strategies to average down on Clearmind Medicine Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Is Clearmind Medicine Inc. (CWY0) stock a buy for dividend portfolios2025 Historical Comparison & Stock Market Timing Techniques - newser.com
What momentum shifts mean for Clearmind Medicine Inc.2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What dividend safety score for Clearmind Medicine Inc. stock2025 Market Outlook & Weekly High Momentum Picks - newser.com
Best data tools to analyze Clearmind Medicine Inc. stockInsider Selling & Weekly Return Optimization Plans - newser.com
Published on: 2025-11-03 01:01:42 - newser.com
How Clearmind Medicine Inc. stock responds to policy changesQuarterly Market Review & Smart Allocation Stock Tips - newser.com
Will Clearmind Medicine Inc. (CWY0) stock hit analyst forecasts2025 Pullback Review & Real-Time Stock Price Movement Reports - newser.com
Why Clearmind Medicine Inc. stock is trending among retail tradersMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Building trade automation scripts for Clearmind Medicine Inc.Treasury Yields & Weekly Hot Stock Watchlists - newser.com
How Clearmind Medicine Inc. (CWY0) stock trades after earningsMarket Risk Report & AI Powered Market Trend Analysis - newser.com
Is Clearmind Medicine Inc. stock supported by strong fundamentalsJuly 2025 Breakouts & High Conviction Trade Alerts - newser.com
Will Clearmind Medicine Inc. (CWY0) stock outperform Dow Jones2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
What earnings margins imply for Clearmind Medicine Inc. (CWY0) stockWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Is Clearmind Medicine Inc. stock positioned for long term growth2025 Dividend Review & Community Supported Trade Ideas - newser.com
Historical volatility pattern of Clearmind Medicine Inc. visualized2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Applying big data sentiment scoring on Clearmind Medicine Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Clearmind Medicine files patent for cocaine addiction treatment By Investing.com - Investing.com Canada
Clearmind Medicine files patent for cocaine addiction treatment - Investing.com
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - The Manila Times
Clearmind Medicine Advances Fight Against Cocaine Addiction With Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy - 富途牛牛
Using data models to predict Clearmind Medicine Inc. stock movementEarnings Trend Report & Breakout Confirmation Alerts - newser.com
Volatility clustering patterns for Clearmind Medicine Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Is Clearmind Medicine Inc. (CWY0) stock inflation resilientJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):